Assessment of Pediatric Hemolytic Uremic Syndrome Patients Hospitalized in Pediatric Intensive Care Unit

Aim: It is aimed to describe clinical properties and outcomes of pediatric hemolytic uremic syndrome hospitalized in intensive care.
 Material Method: Our study was intended as observatory retrospective. Symptoms before PICU admission, interventions time period admission days were defined pre-PICU findings. Glasgow Coma Score (GCS) at Pediatric Risk Mortality (PRİSM-III), laboratory parameters, medical treatments, extracorporeal treatments data collected interventions. Outcomes examined PICU, hospital survival.
 Results: Twenty-three patients included into study. Before more than half the treated with antibiotics. Twenty-two suffered from diarrhea. 3 had non-bloody central nervous system involvement presented seizures. Intravenous diuretics (86.9%) oral antihypertensives (73.9%) most common PICU. Eculizumab treatment required for 6 patients. All got fresh frozen plasma. Nearly all erythrocyte transfusions (95.6%). If we evaluated renal replacement therapies, 2 (8.6%) needed CRRT 12 (52.7%) IHD. Extrarenal spotted 5 (21.7%). Most survived (95.3%).
 Conclusion: Hemolytic an important clinic entity. patients’ blood pressure could be controlled antihypertensive treatments. Antibiotic prescriptions diarrhetic should cautiously. There transfusion protocols clinics about HUS prevent over transfusion.